American Psychiatric Association's Survey Reveals Public Perception of Safety and Addictiveness of Cannabis and Other Substances
The American Psychiatric Association released results from their annual survey on addictive substances and behaviors.
In a news release from June 8, 2023, the American Psychiatric Association (APA) discussed results from its national survey on Americans’ usage of and opinions on cigarettes, alcohol, opioids, vapes, technology, and cannabis (1). Over 2200 Americans were polled in April of 2023 by APA and Morning Consult, which is part of APA’s Healthy Minds Monthly regular polls (1).
According to one section of the results, cigarettes were viewed as a very or somewhat addictive substance/behavior by 87% of respondents, followed by alcohol (84%) and prescribed opioids (83%) (1). Comparatively, cannabis/marijuana was considered by 64% to be very or somewhat addictive (1).
Out of the 2200 respondents, 38% said cannabis was very or somewhat unsafe, and 13% said they used it daily (1). Only technology was seen a safer substance, and 67% said they used it daily (1). Cigarettes were reported by the most respondents as very or somewhat unsafe (84%) (1).
According to its website, APA was founded in 1844 and currently has more than 38,000 physician members (1).
Reference
- New APA Poll finds Americans rate cigarettes as most unsafe, addictive substance among options surveyed https://www.psychiatry.org/News-room/News-Releases/New-APA-Poll-Finds-Americans-Rate-Cigarettes-as-Mo (accessed Jun 14, 2023).
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.
